15 studies found for:    Machado-Joseph Disease
Show Display Options
Rank Status Study
1 Withdrawn Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: Placebo;   Drug: Sodium Phenylbutyrate
2 Completed Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
Conditions: Spinocerebellar Ataxia Type 3;   Machado Joseph Disease
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
3 Recruiting Machado-Joseph Disease in Israel
Condition: Spinocerebellar Ataxia 3
Intervention:
4 Recruiting The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease
Condition: Machado Joseph Disease (SCA3)
Intervention: Device: Deep TMS
5 Not yet recruiting Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease
Condition: Machado-Joseph Disease / Spinocerebellar Ataxia 3
Intervention: Drug: Cabaletta for IV infusion once weekly during 24 weeks
6 Completed Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: varenicline;   Drug: placebo
7 Unknown  RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Condition: Spinocerebellar Ataxias
Intervention:
8 Recruiting Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6
Intervention: Genetic: All Participants
9 Completed Dalfampridine and Gait in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxias Type 1;   Spinocerebellar Ataxias Type 2;   Spinocerebellar Ataxias Type 3;   Spinocerebellar Ataxias Type 6
Interventions: Drug: Dalfampridine;   Drug: Placebo
10 Completed Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxia
Intervention:
11 Active, not recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
12 Active, not recruiting Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases
Condition: Neurodegenerative Disorders
Intervention:
13 Recruiting Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
14 Recruiting Longitudinal Surveillance Registry (LSR) of ACUITY Spiral
Condition: Heart Failure
Intervention: Device: ACUITY Spiral Left Ventricular Lead
15 Recruiting Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2)
Condition: Advanced, Metastatic Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: Letrozole Placebo

Indicates status has not been verified in more than two years